Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00320905 · ClinicalTrials.gov registry record
Smart Heart Study: Cognitive Benefits of Cardiac Rehabilitation
A clinical trial, sponsored by Summa Health System.
- Completed
- Registry status
- 70
- Enrollment target
NCT00320905 is a clinical trial that has completed, run by Summa Health System. The registered enrollment target is 70 participants.
The verdict
NCT00320905 has completed, sponsored by Summa Health System.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
The proposed study will be the first to examine whether changes in blood flow patterns within the brain account for the possible cognitive benefits of CR. A clearer understanding of this possibility may provide key insight into the way CVD affects the brain, help identify effective treatments, help a greater number of patients return to work, and improve quality of life.
Interventions
- BEHAVIORAL Observational
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2006-03 |
| Est. Completion | 2008-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00320905
The ClinicalTrials.gov registry entry for NCT00320905 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Summa Health System, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observational is the first listed.
NCT00320905 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00320905 about?
NCT00320905 is a clinical study titled "Smart Heart Study: Cognitive Benefits of Cardiac Rehabilitation". The proposed study will be the first to examine whether changes in blood flow patterns within the brain account for the possible cognitive benefits of CR. A clearer understanding of this possibility may provide key insight into the way CVD affects the brain, help identify effective treatments, help ...
What is the current status of trial NCT00320905?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2006-03. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00320905?
The interventions under investigation include: Observational (BEHAVIORAL).
Who is sponsoring clinical trial NCT00320905?
This trial is sponsored by Summa Health System, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.